Skip to main content

HOPA Abstracts

Clinical Pharmacist–Initiated Tyrosine Kinase Inhibitor Discontinuation in Patients with Chronic Myeloid Leukemia
Abstract #CR05
Read More
Evaluation of Chemotherapy-Induced Myelosuppression in Patients with Extensive-Stage Small-Cell Lung Cancer Who Received Trilaciclib: Retrospective Analysis of Florida Community Oncology Practices
Abstract #CR06
Read More
Evaluation of the Safety of the New Alcohol-Containing Formulation of Cyclophosphamide
Abstract #CR07
Read More
Health System Specialty Pharmacy Integration Impact on Prescription Fill Time
Abstract #CR08
Read More
Invasive Fungal Disease in Patients with Hematologic Malignancies Receiving Micafungin Prophylaxis
Abstract #CR09
Read More
Knowledge Gaps and Educational Needs for Common Cancer Therapy–Related Cardiovascular Adverse Events and Related Drug Interactions
Abstract #CR10
Read More
Multidisciplinary Approach in Maximizing Oncology Clinic Throughput in a Comprehensive Cancer Center
Abstract #CR11
Read More
Optimization of Rasburicase Dose for the Management of Tumor Lysis Syndrome in Community Oncology Practices
Abstract #CR12
Read More
Pharmacist-Led 14-Day Oncolytic Drug Check-In Protocol
Abstract #CR13
Read More
Safety of Rapid Dose Escalation of Venetoclax in Patients with Hematologic Malignancies
Abstract #CR14
Read More
Page 9 of 15
Results 81 - 90 of 146